P-Glycoprotein expression in human retinal pigment epithelium cell lines

Experimental Eye Research

Volumn 83, Issue 1, 2006, Pages 24-30

  Constable, Paul A ^a   Lawrenson, John G ^a,b   Dolman, Diana E M ^b   Arden, Geoffrey B ^a   Abbott, N Joan ^b  

^a Applied Vision Research Centre   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

cell lines; drug transport; P glycoprotein; retinal pigment epithelium

Indexed keywords

CD19 ANTIGEN; GLYCOPROTEIN P; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; PROTEIN ANTIBODY; RHODAMINE 123; VERAPAMIL;

ARTICLE; CELL CULTURE; CELL LINE; CELL TYPE; CONTROLLED STUDY; DRUG TRANSPORT; EPITHELIUM CELL; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; NUCLEOTIDE SEQUENCE; PIGMENT EPITHELIUM; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE;

BIOLOGICAL TRANSPORT; CALCIUM CHANNEL BLOCKERS; CELL LINE; CYTOSOL; EYE PROTEINS; GENES, MDR; HUMANS; IMMUNOHISTOCHEMISTRY; P-GLYCOPROTEIN; PIGMENT EPITHELIUM OF EYE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHODAMINES; RNA, MESSENGER; VERAPAMIL;

EID: 33646881303     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2005.10.029     Document Type: Article

References (33)

1. Ambati J., and Adamis A.P. Transscleral drug delivery to the retina and choroid. Prog. Retin. Eye Res. 21 (2002) 145-151
2. Aukunuru J.V., Sunkara G., Bandi N., Thoreson W.B., and Kompella U.B. Expression of multidrug resistance-associated protein (MRP) in human retinal pigment epithelial cells and its interaction with BAPSG, a novel aldose reductase inhibitor. Pharm. Res. 18 (2001) 565-572
3. Begley D.J., Lechardeur D., Chen Z.-D., Rollinson C., Bardoul M., Roux F., Scherman D., and Abbott N.J. Functional expression of P-glycoprotein in an immortalised cell line of rat brain endothelial cells, RBE4. J. Neurochem. 67 (1996) 988-995
4. Cunha-Vaz J. The blood-retinal barriers system. Basic concepts and clinical evaluation. Exp. Eye Res. 78 (2004) 715-721
5. Davis A.A., Bernstein P.S., Bok D., Turner J., Nachtigal M., and Hunt R.C. A human retinal pigment epithelial cell line that retains epithelial characteristics after prolonged culture. Invest. Ophthalmol. Vis. Sci. 36 (1995) 955-964
6. Dunn K.C., Aotaki-Keen A.E., Putkey F.R., and Hjelmeland L.M. ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp. Eye Res. 62 (1996) 155-169
7. Dunn K.C., Marmorstein A.D., Bonilha V.L., Rodriguez-Boulan E., Giordano F., and Hjelmeland L.M. Use of the ARPE-19 cell line as a model of RPE polarity: basolateral secretion of FGF5. Invest. Ophthalmol. Vis. Sci. 39 (1998) 2744-2749
8. Duvvuri S., Majumdar S., and Mitra A.K. Drug delivery to the retina: challenges and opportunities. Expert Opin. Biol. Ther. 3 (2003) 45-56
9. Esser P., Tervooren D., Heimann K., Kociok N., Bartz-Schmidt K.U., Walter P., and Weller M. Intravitreal daunomycin induces multidrug resistance in proliferative vitreoretinopathy. Invest. Ophthalmol. Vis. Sci. 39 (1998) 164-170
10. Gaillard P., van der Sandt I., Voorwinden L., Vu D., Nielsen J., de Boer A., and Breimer D. Astrocytes increase the functional expression of P-glycoprotein in an in vitro model of the blood-brain barrier. Pharm. Res. 17 (2000) 1198-2005
11. Greenwood J. Characterization of a rat retinal endothelial cell culture and the expression of P-glycoprotein in brain and retinal endothelium in vitro. J. Neuroimmunol. 39 (1992) 123-132
12. Greenwood J., Pryce G., Devine L., Male D., dos Santos W., Calder V., and Adamson P. SV40 large T immortalised cell lines of the rat blood-brain and blood-retinal barriers retain their phenotypic and immunological characteristics. J. Neuroimmunol. 71 (1996) 51-63
13. Gumbleton M., and Audus K. Progress and limitations in the use of in vitro cell cultures to serve as a permeability screen for the blood-brain barrier. J. Pharm. Sci. 90 (2001) 1681-1698
14. Hirsch-Ernst K.I., Ziemann C., Schmitzsalue C., Foth H., and Kahl G.F. Modulation of P-glycoprotein and mdr1b mRNA expression by growth factors in primary rat hepatocyte culture. Biochem. Biophys. Res. Commun. 215 (1995) 179-185
15. Jaffe G., Yang C., Wang X., Cousins S., Gallemore R., and Ashton P. Intravitreal sustained-release cyclosporine in the treatment of experimental uveitis. Ophthalmology 105 (1998) 46-56
16. Kanuga N., Winton H.L., Beauchene L., Koman A., Zerbib A., Halford S., Couraud P.O., Keegan D., Coffey P., Lund R.D., Adamson P., and Greenwood J. Characterization of genetically modified human retinal pigment epithelial cells developed for in vitro and transplantation studies. Invest. Ophthalmol. Vis. Sci. 43 (2002) 546-555
17. Kennedy B.G., and Mangini N.J. P-glycoprotein expression in human retinal pigment epithelium. Mol. Vis. 8 (2002) 422-430
18. Kusuhara H., and Sugiyama Y. Efflux transport systems for drugs at the blood-brain barrier and blood-cerebrospinal fluid barrier (part 2). Drug Discov. Today 6 (2001) 206-212
19. Lechardeur D., Schwartz B., Paulin D., and Scherman D. Induction of blood-brain barrier differentiation in a rat brain-derived endothelial cell line. Exp. Cell Res. 220 (1995) 161-170
20. Lund R.D., Adamson P., Sauve Y., Keegan D.J., Girman S.V., Wang S., Winton H., Kanuga N., Kwan A.S., Beauchene L., Zerbib A., Hetherington L., Couraud P.O., Coffey P., and Greenwood J. Subretinal transplantation of genetically modified human cell lines attenuates loss of visual function in dystrophic rats. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 9942-9947
21. Mannerstrom M., Zorn-Kruppa M., Diehl H., Engelke M., Toimela T., Maenpaa H., Huhtala A., Uusitalo H., Salminen L., Pappas P., Marselos M., Mantyla M., Mantyla E., and Tahti H. Evaluation of the cytotoxicity of selected systemic and intravitreally dosed drugs in the cultures of human retinal pigment epithelial cell line and of pig primary retinal pigment epithelial cells. Toxicol. In Vitro 16 (2002) 193-200
22. Mitchell C.H. Release of ATP by a human retinal pigment epithelial cell line: potential for autocrine stimulation through subretinal space. J. Physiol. 534 (2001) 193-202
23. Mizuno N., Niwa T., Yotsumoto Y., and Sugiyama Y. Impact of drug transporter studies on drug discovery and development. Pharmacol. Rev. 55 (2003) 425-461
24. Morlet N., Young S., Strachan D., and Coroneo M. Technique of intravitreal injection. Aust. N.Z. J. Ophthalmol. 21 (1993) 130-131
25. Oddiah D., Anand P., McMahon S.B., and Rattray M. Rapid increase of NGF, BDNF and NT-3 mRNAs in inflamed bladder. Neuroreport 9 (1998) 1455-1458
26. Pastan I., Gottesman M., Ueda K., Lovelace E., Rutherford A., and Willingham M. A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 4486-4490
27. Pham Y., Regina A., Farinotti R., Couraud P., Wainer I., Roux F., and Gimenez F. Interactions of racemic mefloquine and its enantiomers with P-glycoprotein in an immortalised rat brain capillary endothelial cell line, GPNT. Biochem. Biophys. Acta 1524 (2000) 212-219
28. Regina A., Koman A., Piciotti M., El Hafny B., Center M., Bergmann R., Couraud P., and Roux F. Mrp1 multidrug resistance-associated protein and P-glycoprotein expression in rat brain microvessel endothelial cells. J. Neurochem. 71 (1998) 705-715
29. Regina A., Romero I., Greenwood J., Adamson P., Bourre J., Couraud P., and Roux F. Dexamethasone regulation of P-glycoprotein activity in an immortalized rat brain endothelial cell line, GPNT. J. Neurochem. 73 (1999) 1954-1963
30. Schinkel A.H., and Jonker J.W. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv. Drug Deliv. Rev. 55 (2003) 3-29
31. Steuer H., Jaworski A., Elger B., Kaussmann M., Keldenich J., Schneider H., Stoll D., and Schlosshauer B. Functional characterization and comparison of the outer blood-retina barrier and the blood-brain barrier. Invest. Ophthalmol. Vis. Sci. 46 (2005) 1047-1053
32. Tatsuta T., Naito M., Mikami K., and Tsuruo T. Enhanced expression by the brain matrix of P-glycoprotein in brain capillary endothelial cells. Cell Growth Differ. 5 (1994) 1145-1152
33. Velez G., and Whitcup S.M. New developments in sustained release drug delivery for the treatment of intraocular disease. Br. J. Ophthalmol. 83 (1999) 1225-1229